Bookmark

Add to MyYahoo RSS

Pfizer News

News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.

1 hr ago | Business Journal

Accelerator Corp. raises $51M, will expand to New York

Acclerator Corp., a Seattle a life-science investment firm that focuses on biotech businesses, said it's raised $51.1 million in capital funding, and will expand to New York City.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer

2 hrs ago | TheStreet.com

U.S. Stocks Higher as Merck, Pfizer Top Expectations

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Financial Markets, Pfizer, Excaliard Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Mozilla

3 hrs ago | Business Journal

Polaris names former Pfizer exec as area's first female VC partner

Helping reverse a nationwide trend of fewer female venture capitalists in recent years, Polaris Partners has named the only female partner currently at any of the area's top VC firms.

Comment?

Related Topix: Venture Capital, Emerging Technology, Biotech, Medicine, Healthcare Industry

3 hrs ago | Newsday

Earnings: UPS profit slides; Pfizer tops estimates; Merck doubles; Aetna inches higher

United Parcel Service driver Marty Thompson starts his truck up after making a delivery in Cumming, Ga.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Pfizer, Transportation, Trucking, United Parcel Service, Air Courier, Expedited Group, Cumming, GA, Forsyth County, GA

3 hrs ago | PE Hub

Polaris hires Pfizer general counsel Schulman as venture partner

Polaris Partners , which is in the market for a $400 million seventh fund, has brought on board a noted healthcare general counsel.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Waltham, MA

4 hrs ago | Vallejo Times-Herald

Pfizer's 2Q profit sinks 79 pct but tops forecasts

Pfizer's second-quarter earnings plunged 79 percent from last year, when the world's second-largest drugmaker booked a business spinoff gain of more than $10 billion, but results in the most recent quarter still edged analyst expectations.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Collinsville, IL

4 hrs ago | WTHR-TV Indianapolis

Pfizer's 2Q profit sinks 79 pct but tops forecasts

Most of the 1,200 people driven to evacuate by a Northern California wildfire that destroyed 13 homes have been told they can safely return after a series of steady gains in the firefight.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Natural Disasters, Wildfire, Fire

4 hrs ago | Customer Interaction Solutions

Pfizer Reports Second-Quarter 2014 Results

Pfizer Inc. reported financial results for second-quarter 2014. At the beginning of fiscal year 2014, the company began managing its commercial operations through a new global commercial structure consisting of three operating segments: the Global Innovative Pharmaceutical segment ; the Global Vaccines, Oncology and Consumer Healthcare segment ; ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Centers for Disease Control and Prevention

5 hrs ago | The Globe and Mail

Pfizer beats forecasts as cancer medicine sales grow

The Pfizer logo on the exterior of a former Pfizer factory, in the Brooklyn borough of New York, on May 4, 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Associated Press

7 hrs ago | Benzinga

Stocks To Watch For July 29, 2014

Wall Street expects Pfizer to report its Q2 earnings at $0.57 per share on revenue of $12.46 billion.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, Trucking, United Parcel Service, Air Courier, Transportation, Travelers Express Company, Financial Services, Fresh Del Monte Produce, Agriculture

Mon Jul 28, 2014

Wall Street Journal

Wanted: Startups in Biotech

The East Side towers of the Alexandria Center for Life Science have attracted giant pharmaceutical companies such as Pfizer Inc. and Eli Lilly & Co.

Comment?

Related Topix: Biotech, Science / Technology, Medicine, Healthcare Industry, Eli Lilly, Opinion

Seeking Alpha

The Product Development Story Of Provectus Biopharmaceuticals

When Provectus Biopharmaceuticals Inc. announced at the end of May that the FDA had denied it Breakthrough Therapy Designation it caused a sharp drop in the stock price.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Medicine, Healthcare Industry

Seeking Alpha

Whisper Number Impact: How Will Pfizer's Stock Move After Earnings?

Pfizer has a 59% positive surprise history . The overall average post earnings price move is 'positive' when the company reports earnings.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals

Barron's

Pfizer Dips On BMO Downgrade

So concludes BMO Capital Markets today in a downgrade report, which sent shares of Pfizer down nearly 1% to $29.86.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Bristol Myers Squibb, Health, Pain, Enbrel, Etanercept (generic), Celebrex, Celecoxib (generic), Arthritis

Forbes.com

Interesting November Stock Options for Pfizer

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Financial Markets

TheStreet.com

Will This Analyst Downgrade Hurt Pfizer (PFE) Stock Today?

Separately, TheStreet Ratings team rates PFIZER INC as a "buy" with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation: "We rate PFIZER INC a BUY.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

American Reporter

One Woman's WorldLIFE Can Become Too Quiet

The Wall Street Bull Market Express is leaving the station and you have two months, maybe three to run down the platform, take the leap, and latch on to the caboose.

Comment?

Related Topix: Financial Markets, Personal Finance, Retirement, Microsoft, Startups, Biotech, Medicine, Healthcare Industry

Sun Jul 27, 2014

Reuters

Pfizer's need for deal looms larger with earnings report

Pfizer Inc's vulnerability to cheaper generics and its weak roster of experimental medicines will be on display Tuesday when the company reports quarterly earnings, reviving interest in its pursuit of AstraZeneca Plc or other deals to fortify its pipeline.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck , Bristol Myers Squibb, Cancer, Health, Breast Cancer

Benzinga

Earnings Expectations For The Week Of July 28: Exxon, Pfizer, Twitter And Much More

The earnings crunch continues, and reports so far have generally been encouraging.

Comment?

Related Topix: Pfizer, Excaliard Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Exxon Mobil, Energy, Oil & Gas, ExxonMobil Chemical, Chemicals

Sat Jul 26, 2014

Benzinga

Weekly Preview: FOMC In Focus, As Earnings Season Progresses

The US Federal Open Market Committee is set to have a two-day policy meeting next week against a backdrop of geopolitical tension and the US earnings season.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Exxon Mobil, Energy, Oil & Gas, ExxonMobil Chemical, Chemicals

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••